Urinary Bladder, Overactive Clinical Trial
Official title:
The Effects of Transcutaneous Tibial Nerve Stimulation in Sympathetic and Parasympathetic System in Women With Overactive Bladder: Randomized Clinical Trial
The International Continence Society (ICS) defines overactive bladder ( OAB) as a clinical syndrome characterized by urgency with or without urge incontinence , usually accompanied by frequency and nocturia , since in the absence of proven infection or other pathology related . The negative impact on quality of life of patients with OAB is already known. The etiology and pathophysiology of OAB are not completely understood. However, studies indicate an alteration of sympathetic and parasympathetic nerve stimulation involved in the mechanism of OAB. A Transcutaneous Electrical stimulation of the Tibial Nerve ( TENS) has been studied as a noninvasive and inexpensive , treating the symptoms of this syndrome therapeutic way . However, no studies in the literature evaluating the effect of electroconvulsive therapy on the mechanisms involved in sympathetic and parasympathetic modulation in these women . The objective of this study is to investigate the effects of TENS on the sympathetic and parasympathetic system in women with OAB . This is a randomized, double -blind , which will be assessed , first, in a pilot study , 30 female patients with OAB randomly allocated into 2 groups : TENS group and placebo group. Interventions take place in one day assessment of the sympathetic and parasympathetic nervous system are performed . After collecting the data will be analyzed in accordance with the statistical analysis.
Hypothesis True:Electrical stimulation of the tibial nerve (TENS) decreases the activity of
the parasympathetic nervous system and increases the activity of the sympathetic nervous
system in women with overactive bladder.
Null Hypothesis: The electrical stimulation of the tibial nerve (TENS) does not decrease the
activity of the parasympathetic nervous system and does not increase the activity of the
sympathetic nervous system in women with overactive bladder.
Alternative Hypothesis: The electrical stimulation of the tibial nerve (TENS) increases the
activity of the parasympathetic nervous system and decreases the activity of the sympathetic
nervous system in women with overactive bladder.
Intervention Programmes
The randomization technique is carried out through sequential numbers kept in opaque
envelopes, not translucent and closed. This takes into account that a major goal of
randomization is to prevent the researcher to identify which intervention will be performed
in each patient. The generation of sequence numbers will be made by researcher "blind" the
study after patient selection criteria for inclusion and exclusion. The sequence of numbers
to be used for randomization will be kept confidential until the exact moment of the
beginning of the intervention.
In this study, two self-adhesive electrodes, one immediately behind the medial malleolus and
the other 10 cm above will be used. Through a chain of 1Hz, the aim is to correctly identify
the tibial nerve. This position is confirmed with the rhythmic movement of the finger
flexion. The frequency is then changed to 10Hz, the pulse width set at 200 "microseconds"
and adjusted according to the intensity threshold for each patient, below motor threshold.
This current generator also has a device, the VIF (variation in intensity and frequency)
that aims to ease the accommodation of sensory receptors and enhance its effects. The
application time is 30 minutes.
The placebo group will receive active current for 30 seconds and then will gradually
decrease by 15 seconds to not pass any current.
It is noteworthy that all study participants will be instructed not to eat, not drink, not
smoke and do not exercise two hours prior to data collection.
Evaluation of the sympathetic and parasympathetic system For the analysis of Heart Rate
Variability (HRV) time series of RR intervals obtained from continuous ECG signal recorded
(sampling frequency = 1 kHz) for the MP150 system (Biopac, California, USA) will be
interpolated and decimated to obtain equally spaced in time series and then subjected to a
Fast Fourier Transform (FFT) algorithm developed using a Matlab (Matlab 6.0, Mathworks Inc.,
USA) language. The spectral power is calculated by integrating each frequency band of
interest. The time series of RR will be analyzed in the time domain and the frequency and
variability parameters and autonomic balance will be obtained. In the time domain we
calculate the mean values of RR intervals, standard deviation and the square root of the sum
of the square of successive differences (rMSSD). The evaluation of the sympathetic and
parasympathetic nervous system will be held at the Federal University of Health Sciences of
Porto Alegre (UFCSPA), the Laboratory of Physiology before, during and after application of
TENS.
Calculation Sample
Due to lack of studies relating to study the effects of the sympathetic and parasympathetic
TENS in women with overactive bladder nervous system, a pilot study will be conducted which
will consist of:
Group A: TENS Group, composed of 15 women with overactive bladder and Group B: placebo
group, consisting of 15 women with overactive bladder.
Based on the obtained values the actual sample size calculation for the study will be
conducted.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06201013 -
Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children
|
N/A | |
Recruiting |
NCT05880862 -
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
|
Early Phase 1 | |
Recruiting |
NCT04807920 -
BOTOX® at the Time of Prolapse Surgery for OAB
|
Phase 4 | |
Terminated |
NCT02385500 -
Fesoterodine on Urgency Episodes in Parkinson's Disease Population
|
Phase 4 | |
Not yet recruiting |
NCT02477241 -
Brain Areas Involved in Bladder Filling and Contraction
|
N/A | |
Completed |
NCT01698138 -
Prevention of Bladder Dysfunction in Acute Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT00613327 -
An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants
|
Phase 4 | |
Completed |
NCT00527033 -
A Study of YM178 in Patients With Symptomatic Overactive Bladder
|
Phase 2 | |
Completed |
NCT00368706 -
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
|
Phase 3 | |
Recruiting |
NCT04305743 -
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
|
Phase 4 | |
Active, not recruiting |
NCT03681678 -
Laser Therapy for Treatment of Urogenital Symptoms in Women
|
||
Completed |
NCT01655069 -
A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076
|
Phase 3 | |
Completed |
NCT01558856 -
Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder
|
N/A | |
Completed |
NCT01521767 -
Pharmacokinetics and Relative Bioavailability Study
|
Phase 1 | |
Completed |
NCT01381120 -
Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms
|
Phase 4 | |
Completed |
NCT01157377 -
Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence
|
Phase 2 | |
Completed |
NCT01194999 -
Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence
|
Phase 4 | |
Completed |
NCT01262391 -
Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents
|
Phase 1 | |
Completed |
NCT04528784 -
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
|
N/A | |
Completed |
NCT02849418 -
Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity
|
Phase 3 |